References
- Holmes GA. Form of familial degeneration of the cerebellum. Brain. 1908; 30(4): 466-489.
- Bösze P, Skripeczky K, Gaál M, Tóth A, László J. Perrault's syndrome in two sisters. Am J Med Genet. 1983; 16(2): 237-241.
- Amor DJ, Delatycki MB, Gardner RJ, Storey E. New variant of familial cerebellar ataxia with hypergonadotropic hypogonadism and sensorineural deafness. Am J Med Genet. 2001; 99(1): 29-33.
- Georgopoulos NA, Papapetropoulos S, Chroni E, Papadeas ES, Dimopoulos PA, Kyriazopoulout V, Davis MB, Eunson L, Kourounis G, Tzingounist VA. Spinocerebellar ataxia and hypergonadotropic hypogonadism associated with familial sensorineural hearing loss. Gynecol Endocrinol. 2004; 19(2): 105-110.
- Pierce SB, Walsh T, Chisholm KM, Lee MK, Thornton AM, Fiumara A, Opitz JM, Levy-Lahad E, Klevit RE, King MC. Mutations in the DBP-deficiency protein HSD17B4 cause ovarian dysgenesis, hearing loss, and ataxia of Perrault syndrome. Am J Hum Genet. 2010; 87(2): 282-288.
- Fehlow P, Walther F. Richards-Rundle syndrome. Klin Paediatr. 1991; 203(3): 184-186.
- Welsh LW. Alström syndrome: progressive deafness and blindness. Ann Otol Rhinol Laryngol. 2007; 116(4): 281-285.
- Mathis S, Paquis V, Mesnage V, Balaboï I, Gil R, Gilbert B, Neau JP. Wolfram's syndrome presenting as a cerebellar ataxia Rev Neurol. 2007; 163(2): 197-204.
- Finsterer J. Mitochondriopathies. Eur J Neurol. 2004; 11(3): 163-186.
- Nishi Y, Hamamoto K, Kajiyama M, Kawamura I. The Perrault syndrome: clinical report and review. Am J Med Genet. 1988; 31(3): 623-629.
- Ikezoe K, Yamada A, Takeuchi H, Miki H, Katanaka J. A case of early onset cerebellar ataxia with hearing loss, mental disturbance and primary hypogonadism. Rinsho Shinkeigaku. 1992; 32(9): 1032-1034.
- De Michele G, Filla A, Striano S, Rimoldi M, Campanella G. Heterogeneous findings in four cases of cerebellar ataxia associated with hypogonadism (Holmes' type ataxia). Clin Neurol Neurosurg. 1993; 95(1): 23-28.
- Linssen WH, Van den Bent MJ, Brunner HG, Poels PJ. Deafness, sensory neuropathy, and ovarian dysgenesis: a new syndrome or a broader spectrum of Perrault syndrome? Am J Med Genet. 1994; 51(1): 81-82.
- Koskinen T, Pihko H, Voutilainen R. Primary hypogonadism in females with infantile onset spinocerebellar ataxia. Neuropediatrics. 1995; 26(5): 263-266.
- Gottschalk ME, Coker SB, Fox LA. Neurologic anomalies of Perrault syndrome. Am J Med Genet. 1996; 65(4): 274-276.
- Fiumara A, Sorge G, Toscano A, Parano E, Pavone L, Opitz JM. Perrault syndrome: evidence for progressive nervous system involvement. Am J Med Genet A. 2004; 128(3): 246-249.
- McCarthy DJ, Opitz JM. Perrault syndrome in sisters. Am J Med Genet. 1985; 22(3): 629-631.
- Kobe C, Kracht LW, Timmermann L, Bachmann J, Schmidt MC. Perrault Syndrome with progressive nervous system involvement. Clin Nucl Med. 2008; 33(12): 922-924.
- Marlin S, Lacombe D, Jonard L, Leboulanger N, Bonneau D, Goizet C, de Villemeur TB, Cabrol S, Houang M, Moatti L, Feldmann D, Denoyelle F. Perrault syndrome: report of four new cases, review and exclusion of candidate genes. Am J Med Genet A. 2008;146(5):661-664.
- Pallister PD, Opitz JM. 1979. The Perrault syndrome: Autosomal recessive ovarian dysgenesis with facultative, non-sex-limited sensorineural deafness. Am J Med Genet. 4(3): 239-246.
- Anttonen AK, Mahjneh I, Hämäläinen RH, Lagier-Tourenne C, Kopra O, Waris L, Anttonen M, Joensuu T, Kalimo H, Paetau A, Tranebjaerg L, Chaigne D, Loenig M, Eeg-Olofsson O, Udd B, Somer M, Somer H, Lehesjoki AE. The gene disrupted in Marinesco-Sjögren syndrome encodes SIL1, an HSPA5 cochaperone. Nat Genet 2005; 37(12): 1309-1311.
- Beysen D, De Paepe A, De Baere E. FOXL2 mutations and genomic rearrangements in BPES. Hum Mutat. 2009; 30(2): 158-169.
- de Launoit Y, Adamski J. Unique multifunctional HSD17B4 gene product: 17beta-hydroxysteroid dehydrogenase 4 and D-3-hydroxyacyl-coenzyme A dehydrogenase/hydratase involved in Zellweger syndrome. J Mol Endocrinol. 1999; 22(3): 227-240.
- Quinzii CM, Hirano M. Coenzyme Q and mitochondrial disease. Dev Disabil Res Rev. 2010; 16(2):183-188.
- Gempel K, Topaloglu H, Talim B, Schneiderat P, Schoser BG, Hans VH, Pálmafy B, Kale G, Tokatli A, Quinzii C, Hirano M, Naini A, DiMauro S, Prokisch H, Lochmüller H, Horvath R. The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. Brain. 2007; 130(Pt. 8): 2037-2044.
- Finsterer J. Ataxias with autosomal, X-chromosomal or maternal inheritance. Can J Neurol Sci. 2009; 36(4): 409-428.
- Matsunaga T. Value of genetic testing in the otological approach for sensorineural hearing loss. Keio J Med. 2009; 58(4): 216-222.
- Wenstrom KD. Fragile X and other trinucleotide repeat diseases. Obstet Gynecol Clin North Am. 2002; 29(2): 367-388.
- Girard D, Petrovsky N. Alström syndrome: insights into the pathogenesis of metabolic disorders. Nat Rev Endocrinol. 2011; 7(2): 77-88.
- Swerdlow RH. The neurodegenerative mitochondriopathies. J Alzheimers Dis. 2009; 17(4): 737-751.
- Liang WC, Nishino I. State of the art in muscle lipid diseases. Acta Myol. 2010; 29(2): 351-356.
- Petit C. Usher syndrome: from genetics to pathogenesis. Annu Rev Genomics Hum Genet. 2001; 2: 271-297.
- Timmons M, Tsokos M, Asab MA, Seminara SB, Zirzow GC, Kaneski CR, Heiss JD, van der Knaap MS, Vanier MT, Schiffmann R, Wong K. Peripheral and central hypomyelination with hypogonadotropic hypogonadism and hypodontia Neurology, 2006; 67(11): 2066-2069.
- Crandall BF, Samec L, Sparkes RS. A familial syndrome of deafness, alopecia and hypogonadism. J Pediatr. 1973; 82(3): 461-465.
- Sohval AR, Soffer LJ. Congenital familial testicular deficiency. Am J Med. 1953; 14(3): 328-348.
- Woodhouse NJ, Sakati NA. A syndrome of hypogonadism, alopecia, diabetes mellitus, mental retardation, deafness, and ECG abnormalities. J Med Genet. 1983; 20(3): 216-219.
- Nicolaides P, Appleton RE, Fryer A. Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS): a new syndrome. J Med Genet. 1996; 33(5): 419-421.
- Pierce SB, Chisholm KM, Lynch ED, Lee MK, Walsh T, Opitz JM, Li W, Klevit RE, King MC. Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome. Proc Natl Acad Sci USA. 2011; 108(16): 6543-6548.
- Gironi M, Lamperti C, Nemni R, Moggio M, Comi G, Guerini FR, Ferrante P, Canal N, Naini A, Bresolin N, DiMauro S. Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency. Neurology. 2004; 62(5): 818-820.
- Ienco EC, Simoncini C, Orsucci D, Petrucci L, Filosto M, Mancuso M, Siciliano G. May "mitochondrial eve" and mitochondrial haplogroups play a role in neurodegeneration and Alzheimer's disease? Int J Alzheimers Dis. 2011; 2011: 709061.
- Leipnitz G, Amaral AU, Zanatta A, Seminotti B, Fernandes CG, Knebel LA, Vargas CR, Wajner M. Neurochemical evidence that phytanic acid induces oxidative damage and reduces the antioxidant defenses in cerebellum and cerebral cortex of rats. Life Sci. 2010; 87(9-10): 275-280.
- Hogstrom L, Mark J. Fragile X syndrome: relation to premature ovarian failure and infertility treatment. Acta Obstet Gynecol Scand. 2007; 86(2): 244-246.
- Senderek J, Krieger M, Stendel C, Bergmann C, Moser M, Breitbach-Faller N, Rudnik-Schöneborn S, Blaschek A, Wolf NI, Harting I, North K, Smith J, Muntoni F, Brockington M, Quijano-Roy S, Renault F, Herrmann R, Hendershot LM, Schröder JM, Lochmüller H, Topaloglu H, Voit T, Weis J, Ebinger F, Zerres K. Mutations in SIL1 cause Marinesco-Sjögren syndrome, a cerebellar ataxia with cataract and myopathy. Nat Genet. 2005; 37(12): 1312-1314.
- Leslie ND. Insights into the pathogenesis of galactosemia. Annu Rev Nutr. 2003; 23: 59-80.
- Pandolfo M. Friedreich ataxia. Arch Neurol. 2008; 65(10): 1296-1303.
- Koutnikova H, Campuzano V, Foury F, Dolle P, Cazzalini O, Koenig M. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet. 1997; 16(4): 345-351.
- Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, Greenamyre JT. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat Neurosci. 2002; 5(8): 731-736.
- Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D. Transcriptional repression of PGC-1α by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell. 2006; 127(1): 59-69.
- Halpin C, Owen G, Gutiérrez-Espeleta G, Sims K, Rehm H. Audiologic features of Norrie disease. Ann Otol Rhinol Laryngol. 2005; 114(7): 533-538.
- Manaviat MR, Rashidi M, Mohammadi SM. Wolfram Syndrome presenting with optic atrophy and diabetes mellitus: two case reports. Cases J. 2009; 2: 9355.
- Reiners J, Nagel-Wolfrum K, Jürgens K, Märker T, Wolfrum U. Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease. Exp Eye Res. 2006; 83(1): 97-119.
- Kokotas H, Van Laer L, Grigoriadou M, Iliadou V, Economides J, Pomoni S, Pampanos A, Eleftheriades N, Ferekidou E, Korres S, Giannoulia-Karantana A, Van Camp G, Petersen MB. Strong linkage disequilibrium for the frequent GJB2 35delG mutation in the Greek population. Am J Med Genet A. 2008; 146A(22): 2879-2884.
- Baloh RH, Schmidt RE, Pestronk A, Milbrandt J. Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations. J Neurosci. 2007; 27(2): 422-430.
- Schneider C, Reiners K, Toyka KV. Myotonic dystrophy (DM/Curschmann-Steinert disease) and proximal myotonic myopathy (PROMM/Ricker syndrome). Myotonic muscle diseases with multisystemic manifestations. Nervenarzt. 2001; 72(8): 618-624.
- Badano JL, Mitsuma N, Beales PL, Katsanis N. The ciliopathies: an emerging class of human genetic disorders. Annu Rev Genomics Hum Genet. 2006; 7: 125-148.
- Aguglia U, Annesi G, Pasquinelli G, Spadafora P, Gambardella A, Annesi F, Pasqua AA, Cavalcanti F, Crescibene L, Bagalà A, Bono F, Oliveri RL, Valentino P, Zappia M, Quattrone A. Vitamin E deficiency due to chylomicron retention disease in Marinesco-Sjögren syndrome. Ann Neurol. 2000; 47(2): 260-264.
- Baldwin EJ, Gibberd FB, Harley C, Sidey MC, Feher MD, Wierzbicki AS. The effectiveness of long-term dietary therapy in the treatment of adult Refsum disease. J Neurol Neurosurg Psychiatry. 2010; 81(9): 954-957.
- McGuinness MC, Wei H, Smith KD. Therapeutic developments in peroxisome biogenesis disorders. Expert Opin Investig Drugs. 2000; 9(9): 1985-1992.
- Perera NJ, Lewis B, Tran H, Fietz M, Sullivan DR. Refsum's disease-use of the intestinal lipase inhibitor, Orlistat, as a novel therapeutic approach to a complex disorder. J Obes. 2011; 2011.pii: Epub 2010 Sep 1.
- Leipnitz G, Amaral AU, Zanatta A, Seminotti B, Fernandes CG, Knebel LA, Vargas CR, Wajner M. Neurochemical evidence that phytanic acid induces oxidative damage and reduces the antioxidant defenses in cerebellum and cerebral cortex of rats. Life Sci. 2010; 87(9-10): 275-280.
- Adibhatla RM, Hatcher JF. Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2010; 12(1): 125-169.
- Passage E, Norreel JC, Noack-Fraissignes P, Sanguedolce V, Pizant J, Thirion X, Robaglia-Schlupp A, Pellissier JF, Fontés M. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med. 2004; 10(4): 396-401.
- Williams DS. Usher syndrome: animal models, retinal function of Usher proteins, and prospects for gene therapy. Vision Res. 2008; 48(3): 433-441.